FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy
Related Topics >> FDA regulation | OTC

FDA experts mull ban on child cold meds

Tools

Did drug makers go far enough when they pulled infant cough-and-cold remedies from store shelves last week? Maybe not, the FDA says. An advisory panel convened to discuss the over-the-counter meds is weighing the evidence: that every study of pediatric cold products shows they don't work; that dosing is confusing; and that some research concludes the meds are dangerous. One FDA official told the committee to consider banning them.

Obviously, the drug industry doesn't want to lose these products. The Consumer Health Productions Association is promising an educational campaign to teach parents to use the products properly and avoid overdose. But another powerful group is set against them: pediatricians, who originally lobbied the FDA to take up the issue.

- read the New York Times report

Related Articles:
Drug makers recall infant cold meds. Report
FDA to review OTC cough medicine safety. Report

Twitter   Facebook   LinkedIn   StumbleUpon  
Get Your FREE FiercePharma Email Newsletter:
Be the first to comment
More stories about FDA regulation   OTC  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.